SC 13G/A: OnKure Therapeutics, Inc.
Ticker: OKUR · Form: SC 13G/A · Filed: Nov 14, 2024 · CIK: 1637715
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by OnKure Therapeutics, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,459 words · 6 min read · ~5 pages · Grade level 10.7 · Accepted 2024-11-14 16:00:05
Key Financial Figures
- $0.0001 — ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti
Filing Documents
- okur1015243sc13ga1.htm (SC 13G/A) — 100KB
- 0001214659-24-019110.txt ( ) — 102KB
(a). Name of Issuer
Item 1(a). Name of Issuer: OnKure Therapeutics, Inc., a Delaware corporation, formerly known as Reneo Pharmaceuticals, Inc. (the “Issuer”)
(b). Address of Issuer’s Principal Executive Offices
Item 1(b). Address of Issuer’s Principal Executive Offices: 6707 Winchester Circle, Suite 400, Boulder, CO 80301
(a). Name of Person Filing
Item 2(a). Name of Person Filing: This Statement on Schedule 13G (this “Statement”) is filed by Tang Capital Management, LLC, the general partner of Tang Capital Partners, LP (“Tang Capital Management”); Kevin Tang, the manager of Tang Capital Management and the Chief Executive Officer of Concentra Biosciences, LLC; Tang Capital Partners, LP (“Tang Capital Partners”); and Concentra Biosciences, LLC, an affiliate of Tang Capital Partners (“Concentra”).
(b). Address of Principal Business Office
Item 2(b). Address of Principal Business Office or, if none, Residence: 4747 Executive Drive, Suite 210, San Diego, CA 92121
(c). Citizenship
Item 2(c). Citizenship: Tang Capital Management is a Delaware limited liability company. Mr. Tang is a United States citizen. Tang Capital Partners is a Delaware limited partnership. Concentra is a Delaware limited liability company.
(d). Title of Class of Securities
Item 2(d). Title of Class of Securities: Common Stock, par value $0.0001 per share
(e). CUSIP Number 68277Q105
Item 2(e). CUSIP Number 68277Q105
Not applicable
Item 3. Not applicable.
Ownership
Item 4. Ownership. (a) Amount Beneficially Owned: Tang Capital Management. Tang Capital Management beneficially owns 294,626 shares of the Issuer’s Common Stock. Tang Capital Management shares voting and dispositive power over such shares with Tang Capital Partners and Kevin Tang. Kevin Tang. Kevin Tang beneficially owns 294,626 shares of the Issuer’s Common Stock. Page 6 of 9 pages Kevin Tang shares voting and dispositive power over such shares with Tang Capital Partners and Tang Capital Management. Tang Capital Partners. Tang Capital Partners beneficially owns 294,626 shares of the Issuer’s Common Stock. Tang Capital Partners shares voting and dispositive power over such shares with Tang Capital Management and Kevin Tang. The percentages used herein are based on 12,652,811 shares of Common Stock outstanding as of October 4, 2024, as set forth in the Issuer’s Current Report filed on Form 8-K that was filed with the Securities and Exchange Commission on October 8, 2024. (b) Percent of Class: Tang Capital Management 2.3% Kevin Tang 2.3% Tang Capital Partners 2.3% Concentra 0.0% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Tang Capital Management 0 shares Kevin Tang 0 shares Tang Capital Partners 0 shares Concentra 0 shares (ii) shared power to vote or to direct the vote: Tang Capital Management 294,626 shares Kevin Tang 294,626 shares Tang Capital Partners 294,626 shares Concentra 0 shares (iii) sole power to dispose or to direct the disposition of: Tang Capital Management 0 shares Kevin Tang 0 shares Tang Capital Partners 0 shares Concentra 0 shares Page 7 of 9 pages (iv) shared power to dispose or to direct the disposition of: Tang Capital Management 294,626 shares Kevin Tang 294,626 shares Tang Capital Partners 294,626 shares Concentra 0 shares
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x
Ownership of More than Five Percent on Behalf of Another Person
Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable.
Identification and Classification of Members of the Group
Item 8. Identification and Classification of Members of the Group. Not applicable.
Notice of Dissolution of Group
Item 9. Notice of Dissolution of Group. Not applicable.
Certification
Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 8 of 9 pages Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: November 14, 2024 TANG CAPITAL PARTNERS, LP By: Tang Capital Management, LLC, its General Partner By: /s/ Kevin Tang Kevin Tang, Manager TANG CAPITAL MANAGEMENT, LLC By: /s/ Kevin Tang Kevin Tang, Manager /s/ Kevin Tang Kevin Tang CONCENTRA BIOSCIENCES, LLC By: /s/ Kevin Tang Kevin Tang, Chief Executive Officer Page 9 of 9 Pages